The International Journal of Medical Science and Clinical Invention (IJMSCI) takes the issue of plagiarism very seriously and has a strict policy against it. Plagiarism is the use of someone else's work or ideas without proper attribution and is a serious breach of ethical standards in scientific publishing.

Definition of Plagiarism:

Plagiarism is defined as the reuse of significant portions of text from a source without proper attribution. This can include direct copying, paraphrasing, or the submission of work that has already been published elsewhere without proper permission.

Detection of Plagiarism:

IJMSCI uses plagiarism detection software to screen all submissions for evidence of plagiarism. In cases where plagiarism is detected, the authors will be informed and given an opportunity to provide a written explanation.

Consequences of Plagiarism:

If plagiarism is found to have occurred, IJMSCI may take any of the following actions:

• Rejection of the submission
• Retraction of the publication
• Banning of the authors from future submissions to IJMSCI
• Reporting the incident to the authors' institution or relevant professional body

It is the responsibility of the authors to ensure that their work is original and does not infringe upon the rights of others. By submitting their work to IJMSCI, authors affirm that their work is original and free from plagiarism.

IJMSCI's commitment to fighting plagiarism is part of its broader commitment to maintaining high standards of quality and integrity in scientific publishing. The scientific community relies on the accuracy and reliability of published research, and IJMSCI is dedicated to ensuring that its published content meets these standards.